We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Clinical Research Management System Improves Study Effectiveness

By LabMedica International staff writers
Posted on 19 Apr 2011
A new clinical research management system (CRMS) will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research-billing compliance. More...


Centricity Research, developed by GE Healthcare (Chalfont St. Giles, UK), a global developer of healthcare information technology (HIT), is the industry's first enterprise-class clinical research management solution. Centricity Research helps institutions conducting clinical or translational research manage the growing complexity of research processes and compliance requirements. Centricity Research has robust functionality, built on the foundation of the currently available Centricity Patient Protocol Management solution, to support both the institutions' and researchers' efforts in achieving compliance, enhancing safety, increasing subject recruitment, and facilitating agency audits.

Moreover, GE Healthcare has developed a strategic partnership with mdlogix (Medical Decision Logic, Inc.; Baltimore, MD, USA), which developed its CRMS in collaboration with the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and other leading clinical research institutions. "The enterprise deployment of CRMS at Johns Hopkins includes all departments in the School of Medicine,” said Dr. Dan Ford, vice-dean of clinical research at the Johns Hopkins School of Medicine. "We have over 4,000 protocols currently in CRMS, with over 1,100 of those being active, and approximately 25% of those protocols using CRMS solely at the discretion of the researchers themselves because of the value they gain from the system. CRMS has helped us more efficiently manage the 30% increase we have achieved in the number of research studies conducted at the Johns Hopkins School of Medicine since 2007.”

Centricity Research helps ensure adherence to protocols and maximizes clinical research dollars, while providing the foundation for the continuous improvement of research processes. The platform can integrate with a variety of existing institutional systems, including electronic institutional review board (IRB) systems, electronic medical record/electronic patient record (EMR/EPR) systems, and revenue cycle management (RCM) systems.

Related Links:

GE Healthcare
mdlogix



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Immunofluorescence Analyzer
IFA System
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.